Impact of Net Atrioventricular Compliance on Clinical Outcome in Mitral Stenosis
- 1 November 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 6 (6) , 1001-1008
Abstract
Background—: Net atrioventricular compliance (C n ) has been reported to be an important determinant of pulmonary hypertension in mitral stenosis (MS). We hypothesized that it may be useful in assessing prognosis because C n reflects hemodynamic consequences of MS. To date, limited data with an assumed C n cutoff have indicated the need for larger prospective studies. This prospective study was designed to determine the impact of C n on clinical outcome and its contribution to pulmonary pressure in MS. In addition, we aimed to identify a cutoff value of C n for outcome prediction in this setting. Methods and Results—: A total of 128 patients with rheumatic MS without other significant valve disease were prospectively enrolled. Comprehensive echocardiography was performed and Doppler-derived C n estimated using a previously validated equation. The end point was either mitral valve intervention or death. C n was an important predictor of pulmonary pressure, regardless of classic measures of MS severity. During a median follow-up of 22 months, the end point was reached in 45 patients (35%). Baseline C n predicted outcome, adding prognostic information beyond that provided by mitral valve area and functional status. C n ≤4 mL/mm Hg best predicted unfavorable outcome in derivation and validation sets. A subgroup analysis including only initially asymptomatic patients with moderate to severe MS without initial indication for intervention (40.6% of total) demonstrated that baseline C n predicted subsequent adverse outcome even after adjustment for classic measures of hemodynamic MS severity (hazard ratio, 0.33; 95% confidence interval, 0.14–0.79; P =0.013). Conclusions—: C n contributes to pulmonary hypertension beyond stenosis severity itself. In a wide spectrum of MS severity, C n is a powerful predictor of adverse outcome, adding prognostic value to clinical data and mitral valve area. Importantly, baseline C n predicts a progressive course with subsequent need for intervention in initially asymptomatic patients. C n assessment therefore has potential value for clinical risk stratification and monitoring in MS patients.Keywords
This publication has 36 references indexed in Scilit:
- Pulmonary hypertension with left-sided heart diseaseNature Reviews Cardiology, 2010
- Pulmonary arterial hypertension in rheumatic mitral stenosis: does it affect right ventricular function and outcome after mitral valve replacement?☆Interactive CardioVascular and Thoracic Surgery, 2009
- Two-Dimensional Echocardiographic Methods for Assessment of Left Atrial VolumeThe American Journal of Cardiology, 2006
- Usefulness of Measuring Net Atrioventricular Compliance by Doppler Echocardiography in Patients With Mitral StenosisThe American Journal of Cardiology, 2005
- Factors determining the exercise capacity in mitral stenosisThe American Journal of Cardiology, 1996
- Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cavaThe American Journal of Cardiology, 1990
- Fluid dynamics model of mitral valve flow: Description with in vitro validationJACC, 1989
- Natural History of Mitral Stenosis: A ReviewCirculation, 1972
- The spectrum of pure mitral stenosisThe American Journal of Cardiology, 1962
- The Hemodynamics of the Left Side of the Heart as Studied by Simultaneous Left Atrial, Left Ventricular, and Aortic Pressures; Particular Reference to Mitral StenosisCirculation, 1955